516 related articles for article (PubMed ID: 10919899)
21. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial.
Tyring SK; Plunkett S; Scribner AR; Broker RE; Herrod JN; Handke LT; Wise JM; Martin PA;
J Med Virol; 2012 Aug; 84(8):1224-32. PubMed ID: 22711350
[TBL] [Abstract][Full Text] [Related]
22. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
[TBL] [Abstract][Full Text] [Related]
23. Oral acyclovir in herpes zoster ophthalmicus.
Harding SP; Porter SM
Curr Eye Res; 1991; 10 Suppl():177-82. PubMed ID: 1864092
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal analysis of varicella-zoster virus DNA on the ocular surface associated with herpes zoster ophthalmicus.
Zaal MJ; Völker-Dieben HJ; Wienesen M; D'Amaro J; Kijlstra A
Am J Ophthalmol; 2001 Jan; 131(1):25-9. PubMed ID: 11162975
[TBL] [Abstract][Full Text] [Related]
25. FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial.
Tyring SK; Lee P; Hill GT; Silverfield JC; Moore AY; Matkovits T; Sullivan-Bolyai J
J Med Virol; 2017 Jul; 89(7):1255-1264. PubMed ID: 27943311
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.
Miserocchi E; Modorati G; Galli L; Rama P
Am J Ophthalmol; 2007 Oct; 144(4):547-51. PubMed ID: 17692271
[TBL] [Abstract][Full Text] [Related]
27. Valaciclovir in herpes zoster ophthalmicus: new indication. An empty clinical assessment file.
Prescrire Int; 1999 Jun; 8(41):75-6. PubMed ID: 10558445
[TBL] [Abstract][Full Text] [Related]
28. Herpes zoster guideline of the German Dermatology Society (DDG).
Gross G; Schöfer H; Wassilew S; Friese K; Timm A; Guthoff R; Pau HW; Malin JP; Wutzler P; Doerr HW
J Clin Virol; 2003 Apr; 26(3):277-89; discussion 291-3. PubMed ID: 12637076
[TBL] [Abstract][Full Text] [Related]
29. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group.
Reitano M; Tyring S; Lang W; Thoming C; Worm AM; Borelli S; Chambers LO; Robinson JM; Corey L
J Infect Dis; 1998 Sep; 178(3):603-10. PubMed ID: 9728526
[TBL] [Abstract][Full Text] [Related]
30. Oral acyclovir in the therapy of acute herpes zoster ophthalmicus. An interim report.
Cobo LM; Foulks GN; Liesegang T; Lass J; Sutphin J; Wilhelmus K; Jones DB; Chapman S; Segreti A
Ophthalmology; 1985 Nov; 92(11):1574-83. PubMed ID: 3001610
[TBL] [Abstract][Full Text] [Related]
31. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
Ormrod D; Scott LJ; Perry CM
Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
[TBL] [Abstract][Full Text] [Related]
32. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
Patel R; Bodsworth NJ; Woolley P; Peters B; Vejlsgaard G; Saari S; Gibb A; Robinson J
Genitourin Med; 1997 Apr; 73(2):105-9. PubMed ID: 9215091
[TBL] [Abstract][Full Text] [Related]
33. Comparison of valaciclovir and acyclovir for the treatment of herpes zoster in immunocompetent patients over 50 years of age: a cost-consequence model.
Grant DM; Mauskopf JA; Bell L; Austin R
Pharmacotherapy; 1997; 17(2):333-41. PubMed ID: 9085325
[TBL] [Abstract][Full Text] [Related]
34. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and safety of multiple-dose valaciclovir in geriatric volunteers with and without concomitant diuretic therapy.
Wang LH; Schultz M; Weller S; Smiley ML; Blum MR
Antimicrob Agents Chemother; 1996 Jan; 40(1):80-5. PubMed ID: 8787884
[TBL] [Abstract][Full Text] [Related]
36. Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease.
Jacobson MA; Gallant J; Wang LH; Coakley D; Weller S; Gary D; Squires L; Smiley ML; Blum MR; Feinberg J
Antimicrob Agents Chemother; 1994 Jul; 38(7):1534-40. PubMed ID: 7979285
[TBL] [Abstract][Full Text] [Related]
37. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
Arora A; Mendoza N; Brantley J; Yates B; Dix L; Tyring S
J Infect Dis; 2008 May; 197(9):1289-95. PubMed ID: 18422441
[TBL] [Abstract][Full Text] [Related]
38. Valacyclovir and famciclovir therapy in herpes zoster.
Jubelt B
Curr Neurol Neurosci Rep; 2002 Nov; 2(6):477-8. PubMed ID: 12359099
[No Abstract] [Full Text] [Related]
39. A Network Meta-Analysis of Randomized Clinical Trials to Assess the Efficacy and Safety of Antiviral Agents for Immunocompetent Patients with Herpes Zoster-Associated Pain.
Liu Y; Xiao S; Li J; Long X; Zhang Y; Li X
Pain Physician; 2023 Jul; 26(4):337-346. PubMed ID: 37535772
[TBL] [Abstract][Full Text] [Related]
40. Interventions for men and women with their first episode of genital herpes.
Heslop R; Roberts H; Flower D; Jordan V
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010684. PubMed ID: 27575957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]